Federation Des Caisses Desjardins Du Quebec Harmony Biosciences Holdings, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 49 shares of HRMY stock, worth $1,710. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49
Previous 49
-0.0%
Holding current value
$1,710
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.7MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$231 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$204 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$165 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$79.6 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.2 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.06B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...